GAPDHP51

Across TCGA pan-cancer cohorts, GAPDHP51 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated GAPDHP51 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher GAPDHP51 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated GAPDHP51 expression acts as an unfavorable survival marker, although some lineages such as ESCA and READ show a favorable association.

LUAD, KIRC, and BRCA are the cancer types where GAPDHP51 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	All	0.569	0.702	<.001	85	view →
KIRC	OS	Median	All	0.541	0.700	<.001	80	view →
BRCA	OS	Tertile	All	0.890	0.939	.001	42	view →
MESO	OS	Tertile	IV	0.077	0.638	<.001	36	view →
ESCA	OS	Quartile	III,IV	0.809	0.364	.003	36	view →
READ	DFS	Median	All	0.958	0.703	.004	34	view →
UCS	OS	Median	All	0.542	0.232	.002	18	view →
LAML	DFS	Quartile	All	0.512	0.308	.014	16	view →
THCA	DFS	Tertile	IV	0.686	0.937	.002	15	view →
COAD	OS	Quartile	II,III,IV	0.415	0.720	.012	15	view →
DLBC	DFS	Quartile	III,IV	0.167	0.779	.037	12	view →
KICH	OS	Tertile	III,IV	0.296	0.821	.017	10	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

GAPDHP51–LUAD (DFS)

Open the LUAD breakdown →